Sequencing Strategies: Metastatic Pancreatic Adenocarcinoma

Sequencing Strategies: Metastatic Pancreatic Adenocarcinoma

Episodes

Specialty:

All

Year:

All

EP. 1: Recent Advances in Pancreatic Cancer Research

February 27th 2018

EP. 2: Choosing Frontline Therapy in Metastatic Disease

February 27th 2018

EP. 3: Sequencing Strategies in Pancreatic Cancer

February 27th 2018

EP. 4: Dosing Options With Nab-Paclitaxel/Gemcitabine

February 27th 2018

EP. 5: Pancreatic Cancer: Data With Liposomal Irinotecan/5-FU

February 27th 2018

EP. 6: Impact of Second-Line Approval of Liposomal Irinotecan

February 27th 2018

EP. 7: Second-Line Decision-Making in Pancreatic Cancer

February 27th 2018

EP. 8: Immunotherapy in MSI-High Pancreatic Tumors

February 27th 2018

EP. 9: Pancreatic Cancer: Looking Beyond Second-Line Therapy

February 27th 2018

EP. 10: Promising New Therapies in Pancreatic Cancer

February 27th 2018

EP. 11: Future Outlook in Pancreatic Cancer

February 27th 2018

Trending on OncLive

Epcoritamab Plus R-CHOP Meets PFS End Point in Newly Diagnosed DLBCL

‘Our Impact Will Be Broad and Transformative’: Wells Messersmith, MD, Takes the Reins at CU Anschutz Cancer Center

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

Berzosertib Plus Carboplatin Fails to Improve Responses in Pretreated mCRPC

INBRX-106 Plus Pembrolizumab Improves Responses and PFS in First-Line PD-L1–Positive HNSCC